Wang, D., Qian, G., Zhang, H., Magliocca, K. R., Nannapaneni, S., Amin, A. R., . . . Chen, Z. G. (2016). HER3 targeting sensitizes HNSCC to cetuximab by reducing HER3 activity and HER2/HER3 dimerization - evidence from cell line and patient derived xenograft models. Clin Cancer Res.
Chicago Stili AlıntıWang, Dongsheng, et al. "HER3 Targeting Sensitizes HNSCC to Cetuximab By Reducing HER3 Activity and HER2/HER3 Dimerization - Evidence From Cell Line and Patient Derived Xenograft Models." Clin Cancer Res 2016.
MLA AlıntıWang, Dongsheng, et al. "HER3 Targeting Sensitizes HNSCC to Cetuximab By Reducing HER3 Activity and HER2/HER3 Dimerization - Evidence From Cell Line and Patient Derived Xenograft Models." Clin Cancer Res 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..